Your browser doesn't support javascript.
loading
Deletion of CPEB1 Gene: A Rare but Recurrent Cause of Premature Ovarian Insufficiency.
Hyon, C; Mansour-Hendili, L; Chantot-Bastaraud, S; Donadille, B; Kerlan, V; Dodé, C; Jonard, S; Delemer, B; Gompel, A; Reznik, Y; Touraine, P; Siffroi, J P; Christin-Maitre, S.
Affiliation
  • Hyon C; Département de Génétique Médicale (C.H., L.M.H., S.C.B., J.P.S.), Assistance Publique-Hôpitaux de Paris (AP-HP), Groupe Hospitalier Universitaire de l'Est Parisien-Hôpital Armand Trousseau, 75012, Paris, France; Institut National de la Santé et de la Recherche Médicale (INSERM), UMRS 933, Physiopath
  • Mansour-Hendili L; Département de Génétique Médicale (C.H., L.M.H., S.C.B., J.P.S.), Assistance Publique-Hôpitaux de Paris (AP-HP), Groupe Hospitalier Universitaire de l'Est Parisien-Hôpital Armand Trousseau, 75012, Paris, France; Institut National de la Santé et de la Recherche Médicale (INSERM), UMRS 933, Physiopath
  • Chantot-Bastaraud S; Département de Génétique Médicale (C.H., L.M.H., S.C.B., J.P.S.), Assistance Publique-Hôpitaux de Paris (AP-HP), Groupe Hospitalier Universitaire de l'Est Parisien-Hôpital Armand Trousseau, 75012, Paris, France; Institut National de la Santé et de la Recherche Médicale (INSERM), UMRS 933, Physiopath
  • Donadille B; Département de Génétique Médicale (C.H., L.M.H., S.C.B., J.P.S.), Assistance Publique-Hôpitaux de Paris (AP-HP), Groupe Hospitalier Universitaire de l'Est Parisien-Hôpital Armand Trousseau, 75012, Paris, France; Institut National de la Santé et de la Recherche Médicale (INSERM), UMRS 933, Physiopath
  • Kerlan V; Département de Génétique Médicale (C.H., L.M.H., S.C.B., J.P.S.), Assistance Publique-Hôpitaux de Paris (AP-HP), Groupe Hospitalier Universitaire de l'Est Parisien-Hôpital Armand Trousseau, 75012, Paris, France; Institut National de la Santé et de la Recherche Médicale (INSERM), UMRS 933, Physiopath
  • Dodé C; Département de Génétique Médicale (C.H., L.M.H., S.C.B., J.P.S.), Assistance Publique-Hôpitaux de Paris (AP-HP), Groupe Hospitalier Universitaire de l'Est Parisien-Hôpital Armand Trousseau, 75012, Paris, France; Institut National de la Santé et de la Recherche Médicale (INSERM), UMRS 933, Physiopath
  • Jonard S; Département de Génétique Médicale (C.H., L.M.H., S.C.B., J.P.S.), Assistance Publique-Hôpitaux de Paris (AP-HP), Groupe Hospitalier Universitaire de l'Est Parisien-Hôpital Armand Trousseau, 75012, Paris, France; Institut National de la Santé et de la Recherche Médicale (INSERM), UMRS 933, Physiopath
  • Delemer B; Département de Génétique Médicale (C.H., L.M.H., S.C.B., J.P.S.), Assistance Publique-Hôpitaux de Paris (AP-HP), Groupe Hospitalier Universitaire de l'Est Parisien-Hôpital Armand Trousseau, 75012, Paris, France; Institut National de la Santé et de la Recherche Médicale (INSERM), UMRS 933, Physiopath
  • Gompel A; Département de Génétique Médicale (C.H., L.M.H., S.C.B., J.P.S.), Assistance Publique-Hôpitaux de Paris (AP-HP), Groupe Hospitalier Universitaire de l'Est Parisien-Hôpital Armand Trousseau, 75012, Paris, France; Institut National de la Santé et de la Recherche Médicale (INSERM), UMRS 933, Physiopath
  • Reznik Y; Département de Génétique Médicale (C.H., L.M.H., S.C.B., J.P.S.), Assistance Publique-Hôpitaux de Paris (AP-HP), Groupe Hospitalier Universitaire de l'Est Parisien-Hôpital Armand Trousseau, 75012, Paris, France; Institut National de la Santé et de la Recherche Médicale (INSERM), UMRS 933, Physiopath
  • Touraine P; Département de Génétique Médicale (C.H., L.M.H., S.C.B., J.P.S.), Assistance Publique-Hôpitaux de Paris (AP-HP), Groupe Hospitalier Universitaire de l'Est Parisien-Hôpital Armand Trousseau, 75012, Paris, France; Institut National de la Santé et de la Recherche Médicale (INSERM), UMRS 933, Physiopath
  • Siffroi JP; Département de Génétique Médicale (C.H., L.M.H., S.C.B., J.P.S.), Assistance Publique-Hôpitaux de Paris (AP-HP), Groupe Hospitalier Universitaire de l'Est Parisien-Hôpital Armand Trousseau, 75012, Paris, France; Institut National de la Santé et de la Recherche Médicale (INSERM), UMRS 933, Physiopath
  • Christin-Maitre S; Département de Génétique Médicale (C.H., L.M.H., S.C.B., J.P.S.), Assistance Publique-Hôpitaux de Paris (AP-HP), Groupe Hospitalier Universitaire de l'Est Parisien-Hôpital Armand Trousseau, 75012, Paris, France; Institut National de la Santé et de la Recherche Médicale (INSERM), UMRS 933, Physiopath
J Clin Endocrinol Metab ; 101(5): 2099-104, 2016 05.
Article in En | MEDLINE | ID: mdl-27003306
ABSTRACT
CONTEXT Premature ovarian insufficiency (POI) may be secondary to chemotherapy, radiotherapy, or environmental factors. Genetic causes are identified in 20-25% of cases, but most POI cases remain idiopathic.

OBJECTIVE:

This study aimed to identify new genes involved in POI and to characterize the implication of CPEB1 gene in POI. DESIGN AND

SETTING:

This was a case report and cohort study replicate conducted in academic medical centers. PATIENTS AND

METHODS:

A deletion including CPEB1 gene was first identified in a patient with primary amenorrhea. Secondly, 191 sporadic POI cases and 68 familial POI cases were included. For each patient, karyotype was normal and FMR1 premutation was excluded. Search for CPEB1 deletions was performed by quantitative multiplex PCR of short fluorescent fragments or DNA microarray analysis. Gene sequencing of CPEB1 was performed for 95 patients.

RESULTS:

We identified three patients carrying a microdeletion in band 15q25.2. The proximal breakpoint, for the three patients, falls within a low-copy repeat region disrupting the CPEB1 gene, which represents a strong candidate gene for POI as it is known to be implicated in oocyte meiosis. No mutation was identified by sequencing CPEB1 gene. Therefore, heterozygous deletion of CPEB1 gene leading to haploinsufficiency could be responsible for POI in humans.

CONCLUSION:

Microdeletions of CPEB1 were identified in 1.3% of patients with POI, whereas no mutation was identified. This microdeletion is rare but recurrent as it is mediated by nonallelic homologous recombination due to the existence of low-copy repeats in the region. This result demonstrates the importance of DNA microarray analysis in etiological evaluation and counseling of patients with POI.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Transcription Factors / Menopause, Premature / Primary Ovarian Insufficiency / Gene Deletion / MRNA Cleavage and Polyadenylation Factors Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans Language: En Journal: J Clin Endocrinol Metab Year: 2016 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Transcription Factors / Menopause, Premature / Primary Ovarian Insufficiency / Gene Deletion / MRNA Cleavage and Polyadenylation Factors Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans Language: En Journal: J Clin Endocrinol Metab Year: 2016 Document type: Article
...